The cellular response elicited by ChAdOx1 nCoV-19 (Astrazeneca) vaccine in a cohort from Rio de Janeiro, Brazil with or without previous SARS-CoV-2 infection
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.